ArticleTargeted oncology2024

Correction to: Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis.

Brigida Anna Maiorano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.